Context and Objectives: Glucose metabolism becomes progressively impaired with older age. Fasting glucose and insulin resistance are risk factors for premature death and other adverse outcomes. We aimed to identifying plasma metabolites associated with altered glucose metabolism and insulin resistance in older community-dwelling adults. Participants and Methods: A targeted metabolomics approach was used to identify plasma metabolites associated with impaired fasting plasma glucose, 2-hour plasma glucose on oral glucose tolerance testing, and homeostatic model assessment insulin resistance (HOMA-IR) in 472 participants who participated in the Baltimore Longitudinal Study of Aging, with a mean (SD) age of 70.7 (9.9) years. Results: We measured 143 plasma metabolites. In ordinal logistic regression analyses, using a false discovery rate of 5% and adjusting for potential confounders, we found that alanine, glutamic acid, and proline were significantly associated with increased odds of abnormal fasting plasma glucose. Phosphatidylcholine (diacyl C34:4, alkyl-acyl C32:1, C32:2, C34:2, C34:3, and C36:3) was associated with decreased odds of abnormal fasting plasma glucose. Glutamic and acid phosphatidylcholine alkyl-acyl C34:2 were associated with increased and decreased odds of 2-hour plasma glucose, respectively. Glutamic acid was associated with increased odds of higher tertiles of HOMA-IR. Glycine; phosphatidylcholine (diacyl C32:0, alkyl-acyl C32:1, C32:2, C34:1, C34:2, C34:3, C36:2, C36:3, C40:5, C40:6, C42:3, C42:4, and C42:5); sphingomyelin C16:0, C24:1, and C26:1; and lysophosphatidylcholine C18:1 were associated with decreased odds of abnormal HOMA-IR. Conclusions: Targeted metabolomics identified four plasma amino acids and 16 plasma lipid species, primarily containing polyunsaturated fatty acids, that were associated with abnormal glucose metabolism and insulin resistance in older adults.
Context and Objectives:Glucose metabolism becomes progressively impaired with older age. Fasting glucose and insulin resistance are risk factors for premature death and other adverse outcomes. We aimed to identifying plasma metabolites associated with altered glucose metabolism and insulin resistance in older community-dwelling adults. Participants and Methods: A targeted metabolomics approach was used to identify plasma metabolites associated with impaired fasting plasma glucose, 2-hour plasma glucose on oral glucose tolerance testing, and homeostatic model assessment insulin resistance (HOMA-IR) in 472 participants who participated in the Baltimore Longitudinal Study of Aging, with a mean (SD) age of 70.7 (9.9) years. Results: We measured 143 plasma metabolites. In ordinal logistic regression analyses, using a false discovery rate of 5% and adjusting for potential confounders, we found that alanine, glutamic acid, and proline were significantly associated with increased odds of abnormal fasting plasma glucose. Phosphatidylcholine (diacyl C34:4, alkyl-acyl C32:1, C32:2, C34:2, C34:3, and C36:3) was associated with decreased odds of abnormal fasting plasma glucose. Glutamic and acid phosphatidylcholine alkyl-acyl C34:2 were associated with increased and decreased odds of 2-hour plasma glucose, respectively. Glutamic acid was associated with increased odds of higher tertiles of HOMA-IR. Glycine; phosphatidylcholine (diacyl C32:0, alkyl-acyl C32:1, C32:2, C34:1, C34:2, C34:3, C36:2, C36:3, C40:5, C40:6, C42:3, C42:4, and C42:5); sphingomyelin C16:0, C24:1, and C26:1; and lysophosphatidylcholine C18:1 were associated with decreased odds of abnormal HOMA-IR. Conclusions: Targeted metabolomics identified four plasma amino acids and 16 plasma lipid species, primarily containing polyunsaturated fatty acids, that were associated with abnormal glucose metabolism and insulin resistance in older adults.
Authors: Melissa K Tuck; Daniel W Chan; David Chia; Andrew K Godwin; William E Grizzle; Karl E Krueger; William Rom; Martin Sanda; Lynn Sorbara; Sanford Stass; Wendy Wang; Dean E Brenner Journal: J Proteome Res Date: 2009-01 Impact factor: 4.466
Authors: Erin L Glynn; Lucy W Piner; Kim M Huffman; Cris A Slentz; Lorraine Elliot-Penry; Hiba AbouAssi; Phillip J White; James R Bain; Michael J Muehlbauer; Olga R Ilkayeva; Robert D Stevens; Kathryn N Porter Starr; Connie W Bales; Elena Volpi; M Julia Brosnan; Jeff K Trimmer; Timothy P Rolph; Christopher B Newgard; William E Kraus Journal: Diabetologia Date: 2015-08-09 Impact factor: 10.122
Authors: Rita R Kalyani; Jing Tian; Qian-Li Xue; Jeremy Walston; Anne R Cappola; Linda P Fried; Frederick L Brancati; Caroline S Blaum Journal: J Am Geriatr Soc Date: 2012-08-10 Impact factor: 5.562
Authors: E Jeffrey Metter; B Gwen Windham; Marcello Maggio; Eleanor M Simonsick; Shari M Ling; Josephine M Egan; Luigi Ferrucci Journal: Diabetes Care Date: 2008-02-11 Impact factor: 19.112
Authors: Alena Stancáková; Mete Civelek; Niyas K Saleem; Pasi Soininen; Antti J Kangas; Henna Cederberg; Jussi Paananen; Jussi Pihlajamäki; Lori L Bonnycastle; Mario A Morken; Michael Boehnke; Päivi Pajukanta; Aldons J Lusis; Francis S Collins; Johanna Kuusisto; Mika Ala-Korpela; Markku Laakso Journal: Diabetes Date: 2012-05-02 Impact factor: 9.461
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Sara E Long; Melanie H Jacobson; Yuyan Wang; Mengling Liu; Yelena Afanasyeva; Susan J Sumner; Susan McRitchie; David R Kirchner; Sara G Brubaker; Shilpi S Mehta-Lee; Linda G Kahn; Leonardo Trasande Journal: Int J Obes (Lond) Date: 2022-04-11 Impact factor: 5.551
Authors: Megan M Marron; Stacy G Wendell; Robert M Boudreau; Clary B Clish; Adam J Santanasto; George C Tseng; Joseph M Zmuda; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2020-11-13 Impact factor: 6.053
Authors: Venkatesh L Murthy; Matthew Nayor; Mercedes Carnethon; Jared P Reis; Donald Lloyd-Jones; Norrina B Allen; Robert Kitchen; Paolo Piaggi; Lyn M Steffen; Ramachandran S Vasan; Jane E Freedman; Clary B Clish; Ravi V Shah Journal: Diabetologia Date: 2022-01-18 Impact factor: 10.122
Authors: Nathalie Kliemann; Vivian Viallon; Neil Murphy; Rebecca J Beeken; Joseph A Rothwell; Sabina Rinaldi; Nada Assi; Eline H van Roekel; Julie A Schmidt; Kristin Benjaminsen Borch; Claudia Agnoli; Ann H Rosendahl; Hanna Sartor; José María Huerta; Anne Tjønneland; Jytte Halkjær; Bas Bueno-de-Mesquita; Audrey Gicquiau; David Achaintre; Krasimira Aleksandrova; Matthias B Schulze; Alicia K Heath; Konstantinos K Tsilidis; Giovanna Masala; Salvatore Panico; Rudolf Kaaks; Renée T Fortner; Bethany Van Guelpen; Laure Dossus; Augustin Scalbert; Hector C Keun; Ruth C Travis; Mazda Jenab; Mattias Johansson; Pietro Ferrari; Marc J Gunter Journal: BMC Med Date: 2021-04-30 Impact factor: 8.775
Authors: Maria M Glavas; Queenie Hui; Ian Miao; Fan Yang; Suheda Erener; Kacey J Prentice; Michael B Wheeler; Timothy J Kieffer Journal: Sci Rep Date: 2021-07-07 Impact factor: 4.379
Authors: Debbie S Thompson; Celine Bourdon; Paraskevi Massara; Michael S Boyne; Terrence E Forrester; Gerard Bryan Gonzales; Robert H J Bandsma Journal: JCI Insight Date: 2020-12-17